Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
- 1 August 2003
- journal article
- case report
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 9 (6) , 321-327
- https://doi.org/10.1016/s1353-8020(03)00040-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Risk of second primary malignancies in patients with cutaneous melanomaBritish Journal of Dermatology, 2001
- Melanoma and levodopaJournal of the American Academy of Dermatology, 1998
- Malignant melanoma and levodopa: Is there a relationship? Two new cases and a review of the literatureJournal of the American Academy of Dermatology, 1997
- Safety of Long-term Levodopa Therapy in Malignant MelanomaClinical Neuropharmacology, 1994
- Lid melanoma and parkinsonism.British Journal of Ophthalmology, 1992
- Impaired Levodopa Response in Parkinsonʼs Disease During Melanoma TherapyClinical Neuropharmacology, 1992
- The Use of L-dopa and Carbidopa in Metastatic Malignant MelanomaJournal of Investigative Dermatology, 1991
- Levodopa/Dopamine Analogs as Inhibitors of DNA Synthesis in Human Melanoma Cells.Journal of Investigative Dermatology, 1989
- Levodopa administration and multiple primary cutaneous melanomasArchives of Dermatology, 1980
- Levodopa therapy and malignant melanomaJAMA, 1978